Dennis Molnar has over 30 years of biopharmaceutical industry experience, from healthcare consulting in the 1990s to a series of biopharma company roles in the last two decades. Currently, Mr. Molnar is President and Chief Operating Officer at Apnimed Inc., a company developing the first pill to directly treat obstructive sleep apnea (OSA). There, he oversees non-clinical and CMC operations in coordination with clinical development and
strategic initiatives.
Before joining Apnimed, Dennis led the U.S. operations of Helperby Therapeutics LTD as Chief Executive from 2016 to 2018. From 2001 to 2014, he held several positions of increasing responsibility at Paratek Pharmaceuticals, Inc., located in Boston, MA. From 2012 to 2014, Dennis was CEO of Paratek Pharmaceuticals, helping take the company public through a reverse merger with Transcept Pharmaceuticals in 2014. Dennis served as Director of Finance and Business Development at Magainin Pharmaceuticals from 1998-2000.
Dennis holds an MBA in Health Care Management from the University of Pennsylvania Wharton School and BAs in Biology and Economics from Brown University. He has enjoyed mentoring and coaching ice hockey for more than 30 years, teaching children as young as three to skate, coaching youth and high school hockey teams, founding a women’s learn-to-play ice hockey program, and coaching adult women’s and men’s teams.
- Primary/Complementary Interactive Styles: Mastermind/Romantic
- Interactive Combination: The Social Reformer
- In a film, he’d be played by: Jeff Bridges
- Common Leadership Characteristic: Has a vision for the future that benefits others
